{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T04:53:49Z","timestamp":1791348829502,"version":"4.3.1"},"reference-count":24,"publisher":"Public Library of Science (PLoS)","issue":"3","license":[{"start":{"date-parts":[[2015,3,20]],"date-time":"2015-03-20T00:00:00Z","timestamp":1426809600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"abstract":"<jats:sec id=\"sec001\">\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Some microRNAs (miRNAs) are abnormally expressed in cancer and contribute to tumorigenesis. In the present study, we investigated the role of miR-506 in clear cell renal cell carcinoma (ccRCC).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"sec002\">\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>miR-506 expression was detected in renal cancer cell lines 786-O, ACHN, Caki-1, and Caki-2 and ccRCC specimens by quantitative real-time-PCR. We assessed the association of miR-506 expression with pathology and prognosis in ccRCC patients. We over-expressed and knocked-down miR-506 expression in two renal cancer cell lines, 786-O and ACHN, and assessed the impact on cell proliferation, migration and invasion. A luciferase reporter assay was conducted to confirm the target gene of miR-506 in renal cancer cell lines.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"sec003\">\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>miR-506 was significantly down-regulated in renal cancer cell lines and ccRCC specimens. Low miR-506 expression in ccRCC specimens was associated with an advanced clinical stage and poor prognosis. miR-506 expression was an independent prognostic marker of overall ccRCC patient survival in a multivariate analysis. Over-expression of miR-506 in renal cancer cells decreased cell growth and metastasis, In contrast, down-regulation of miR-506 expression promoted renal cancer cell growth and metastasis. FLOT1, a potential target gene of miR-506, was inversely correlated with miR-506 expression in ccRCC tissues. Consistent with the effect of miR-506, knockdown of FLOT1 by siRNA inhibited cell malignant behaviors. Rescue of FLOT1 expression partially restored the effects of miR-506.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"sec004\">\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>miR-506 exerts its anti-cancer function by directly targeting FLOT1 in renal cancer, indicating a potential novel therapeutic role in renal cancer treatment.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1371\/journal.pone.0120258","type":"journal-article","created":{"date-parts":[[2015,3,20]],"date-time":"2015-03-20T15:11:52Z","timestamp":1426864312000},"page":"e0120258","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":39,"title":["RETRACTED: MiR-506 Is Down-Regulated in Clear Cell Renal Cell Carcinoma and Inhibits Cell Growth and Metastasis via Targeting FLOT1"],"prefix":"10.1371","volume":"10","author":[{"given":"Feng-qiang","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hai-ming","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shao-Jun","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun-hua","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2015,3,20]]},"reference":[{"key":"pone.0120258.ref001","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1440-1827.2009.02477.x","article-title":"Non-invasive papillary urothelial neoplasms: the 2004 WHO\/ISUP classification system","volume":"60","author":"H Miyamoto","year":"2010","journal-title":"Pathol Int"},{"key":"pone.0120258.ref002","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1002\/cncr.21331","article-title":"Comparison of predictive accuracy of four prognostic models for nonmetastatic renal cell carcinoma after nephrectomy: a multicenter European study","volume":"104","author":"L Cindolo","year":"2005","journal-title":"Cancer"},{"key":"pone.0120258.ref003","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1200\/JCO.2006.06.1218","article-title":"Multi-institutional validation of a new renal cancer-specific survival nomogram","volume":"25","author":"PI Karakiewicz","year":"2007","journal-title":"J Clin Oncol"},{"key":"pone.0120258.ref004","doi-asserted-by":"crossref","first-page":"5579","DOI":"10.1158\/1078-0432.CCR-08-0504","article-title":"Combination of quantitative IMP3 and tumor stage: a new system to predict metastasis for patients with localized renal cell carcinomas","volume":"14","author":"Z Jiang","year":"2008","journal-title":"Clin Cancer Res"},{"key":"pone.0120258.ref005","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1002\/cncr.24713","article-title":"Stage migration and increasing proportion of favorable-prognosis metastatic renal cell carcinoma patients: implications for clinical trial design and interpretation","volume":"116","author":"S Patil","year":"2010","journal-title":"Cancer"},{"key":"pone.0120258.ref006","doi-asserted-by":"crossref","first-page":"6156","DOI":"10.1038\/sj.onc.1209908","article-title":"Principles of micro-RNA production and maturation","volume":"25","author":"Y Zeng","year":"2006","journal-title":"Oncogene"},{"key":"pone.0120258.ref007","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.aca.2011.05.025","article-title":"Analytical aspects of microRNA in diagnostics: a review","volume":"699","author":"M de Planell-Saguer","year":"2011","journal-title":"Anal Chim Acta"},{"key":"pone.0120258.ref008","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1038\/nrc3166","article-title":"Epigenetics and genetics. MicroRNAs en route to the clinic: progress in validating and targeting microRNAs for cancer therapy","volume":"11","author":"AL Kasinski","year":"2011","journal-title":"Nat Rev Cancer"},{"key":"pone.0120258.ref009","first-page":"223","article-title":"MicroRNAs as oncogenes and tumor Suppressors","author":"EE Rufino-Palomares","year":"2014","journal-title":"MicroRNAs in Medicine"},{"key":"pone.0120258.ref010","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1097\/CCO.0b013e328358522c","article-title":"Potential of microRNAs for cancer diagnostics, prognostication and therapy","volume":"24","author":"R Garzon","year":"2012","journal-title":"Curr Opin Oncol"},{"key":"pone.0120258.ref011","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1016\/j.biocel.2009.12.014","article-title":"MicroRNAs: potential biomarkers for cancer diagnosis, prognosis and targets for therapy","volume":"42","author":"WC Cho","year":"2010","journal-title":"Int J Biochem Cell Biol"},{"key":"pone.0120258.ref012","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1038\/ng1590","article-title":"Identification of hundreds of conserved and nonconserved human microRNAs","volume":"37","author":"I Bentwich","year":"2005","journal-title":"Nat Genet"},{"key":"pone.0120258.ref013","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1002\/hep.25691","article-title":"Upregulation of mir-506 leads to decreased AE2 expression in biliary epithelium of patients with primary biliary cirrhosis","volume":"56","author":"JM Banales","year":"2012","journal-title":"Hepatology (Baltimore, Md)"},{"key":"pone.0120258.ref014","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.toxlet.2011.06.022","article-title":"The role of miR-506 in transformed 16HBE cells induced by anti-benzo[a]pyrene-trans-7,8-dihydrodiol-9,10-epoxide","volume":"205","author":"Y Zhao","year":"2011","journal-title":"Toxicol Lett"},{"key":"pone.0120258.ref015","doi-asserted-by":"crossref","first-page":"e64273","DOI":"10.1371\/journal.pone.0064273","article-title":"miR-506 regulates epithelial mesenchymal transition in breast cancer cell lines","volume":"8","author":"H Arora","year":"2013","journal-title":"PloS one"},{"key":"pone.0120258.ref016","doi-asserted-by":"crossref","unstructured":"Wen S, Lin Y, Yu Y, Cao S, Zhang R, Yang X, et al. miR-506 acts as a tumor suppressor by directly targeting the hedgehog pathway transcription factor Gli3 in human cervical cancer. Oncogene. 2014.","DOI":"10.1038\/onc.2014.9"},{"key":"pone.0120258.ref017","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1002\/path.4348","article-title":"MiR506 suppresses\u2010 proliferation and induces senescence by directly targeting the CDK4\/6\u2013FOXM1 axis in ovarian cancer","volume":"233","author":"G Liu","year":"2014","journal-title":"J Pathol"},{"key":"pone.0120258.ref018","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/j.ejcb.2007.03.003","article-title":"Dissecting the molecular function of reggie\/flotillin proteins","volume":"86","author":"T Babuke","year":"2007","journal-title":"Eur J Cell Biol"},{"key":"pone.0120258.ref019","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1242\/jcs.039024","article-title":"Endocytosis of flotillin-1 and flotillin-2 is regulated by Fyn kinase","volume":"122","author":"K Riento","year":"2009","journal-title":"J Cell Sci"},{"key":"pone.0120258.ref020","doi-asserted-by":"crossref","first-page":"3311","DOI":"10.1007\/s13277-013-1434-3","article-title":"Abnormal expression of FLOT1 correlates with tumor progression and poor survival in patients with non-small cell lung cancer","volume":"35","author":"H Li","year":"2014","journal-title":"Tumour Biol"},{"key":"pone.0120258.ref021","doi-asserted-by":"crossref","first-page":"3089","DOI":"10.1158\/1078-0432.CCR-10-3068","article-title":"Knockdown of FLOT1 impairs cell proliferation and tumorigenicity in breast cancer through upregulation of FOXO3a","volume":"17","author":"C Lin","year":"2011","journal-title":"Clinical Cancer Research"},{"key":"pone.0120258.ref022","doi-asserted-by":"crossref","first-page":"e64709","DOI":"10.1371\/journal.pone.0064709","article-title":"High expression of FLOT1 is associated with progression and poor prognosis in hepatocellular carcinoma","volume":"8","author":"S-H Zhang","year":"2013","journal-title":"PloS one"},{"key":"pone.0120258.ref023","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1093\/carcin\/bgs140","article-title":"microRNA involvement in human cancer","volume":"33","author":"MV Iorio","year":"2012","journal-title":"Carcinogenesis"},{"key":"pone.0120258.ref024","doi-asserted-by":"crossref","first-page":"395","DOI":"10.4149\/neo_2013_051","article-title":"Flotillin-1 promotes cell growth and metastasis in oral squamous cell carcinoma","volume":"60","author":"P Xiong","year":"2012","journal-title":"Neoplasma"}],"updated-by":[{"DOI":"10.1371\/journal.pone.0129404","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2015,5,26]],"date-time":"2015-05-26T00:00:00Z","timestamp":1432598400000}},{"DOI":"10.1371\/journal.pone.0345812","type":"retraction","label":"Retraction","source":"publisher","updated":{"date-parts":[[2026,3,30]],"date-time":"2026-03-30T00:00:00Z","timestamp":1774828800000}},{"DOI":"10.1371\/journal.pone.0345812","type":"retraction","label":"Retraction","source":"retraction-watch","updated":{"date-parts":[[2026,3,30]],"date-time":"2026-03-30T00:00:00Z","timestamp":1774828800000},"record-id":"73067"},{"DOI":"10.1371\/journal.pone.0129404","type":"correction","label":"Correction","source":"retraction-watch","updated":{"date-parts":[[2015,5,26]],"date-time":"2015-05-26T00:00:00Z","timestamp":1432598400000},"record-id":"73068"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0120258","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,30]],"date-time":"2026-03-30T21:46:20Z","timestamp":1774907180000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0120258"}},"subtitle":[],"editor":[{"given":"Jin Q.","family":"Cheng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2015,3,20]]},"references-count":24,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2015,3,20]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0120258","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,3,20]]}}}